Central Nervous System Lymphoma Clinical Trials in Beijing, Beijing Municipality
7 recruitingBeijing, Beijing Municipality, China
Showing 1–7 of 7 trials
Recruiting
Phase 2
Pomalidomide, Anti-PD-1 Antibody Combined With Selinexor (PPS) in Relapsed/Refractory Primary Central Nervous System Diffuse Large B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma (DLBCL)Primary Central Nervous System Lymphoma (PCNSL)
Beijing Tongren Hospital43 enrolled1 locationNCT07523737
Recruiting
Phase 1Phase 2
Selinexor in Combination With MTX+Ritu to Treat R/R CNSL
Central Nervous System Lymphoma
Tong Chen, MD30 enrolled5 locationsNCT05698147
Recruiting
Phase 1Phase 2
Fourth-gen CAR T Cells Targeting CD19/CD22 for Highly Resistant B-cell Lymphoma/Leukemia (PMBCL/CNS-BCL).
Diffuse Large B Cell LymphomaAcute Lymphoblastic Leukemia, Adult B-CellAcute Lymphoblastic Leukemia, in Relapse+4 more
Essen Biotech75 enrolled1 locationNCT06213636
Recruiting
Phase 2
Orelabrutinib,Rituximab and Methotrexate in Newly-diagnosed Primary Central Nervous System Lymphoma(PCNSL)
Primary Central Nervous System Lymphoma
Affiliated Hospital to Academy of Military Medical Sciences36 enrolled1 locationNCT05549284
Recruiting
Phase 2
Sequential Treatment With RO-MTX After Pomalidomide, Orelabrutinib, Rituximab (POR) in Newly-diagnosed PCNSL
Primary Central Nervous System Lymphoma
Peking Union Medical College Hospital50 enrolled3 locationsNCT05390749
Recruiting
Phase 2Phase 3
Treatment of PCNSL With R-IDARAM and Intrathecal Immunochemotherapy
Primary Central Nervous System Lymphoma
Navy General Hospital, Beijing100 enrolled1 locationNCT02657785
Recruiting
Phase 2Phase 3
Therapeutic Effects of R-IDARAM and Intrathecal Immunochemotherapy on Elderly Patients With PCNSL
Primary Central Nervous System Lymphoma
Navy General Hospital, Beijing100 enrolled1 locationNCT02836158